Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Registry on Hypomethylating Agents in Myeloid Neoplasms

NCT01595295

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • LKH Feldkirch, Innere Med. II, Interne E Feldkirch, Austria
  • LKH Fürstenfeld Fürstenfeld, Austria
  • UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
  • Universitätsklinik für Innere Medizin V Innsbruck, Austria
View all 20 locations
View Trial Details
Completed

A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)

NCT02632721

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Northwell Health Lake Success, New York, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View all 14 locations
View Trial Details
Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

The EMPATHY Pilot Study

NCT04384848

Conditions
Bone Marrow Diseases, Cancer, Chronic Disease, +12 more
Locations
  • Augusta University, Hematology and Oncology Augusta, Georgia, United States
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center Comprehensive Cancer Center (RHLCCC) Chicago, Illinois, United States
  • Policlinico Sant'Orsola Malpighi - UOC Ematologia - Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO - Azienda Ospedaliera G. Brotzu Cagliari, Italy
View all 16 locations
View Trial Details
Completed

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

NCT03379727

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Pleven, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Varna, Bulgaria
View all 86 locations
View Trial Details
Completed

A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients

NCT03720366

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Local Institution - 103 Concord, New South Wales, Australia
  • Local Institution - 107 Adelaide, South Australia, Australia
  • Local Institution - 106 Clayton, Victoria, Australia
  • Local Institution - 102 Heidelberg, Victoria, Australia
View Trial Details
Completed

Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)

NCT02013648

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Universitätsklinik für Innere Medizin V Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz, Austria
  • Krankenhaus der Elisabethinen Linz GmbH Linz, Austria
  • Universitätsklinik der PMU Salzburg, Austria
View all 54 locations
View Trial Details

Related conditions